Citigroup’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.1M | Sell |
174,072
-14,816
| -8% | -$1.49M | 0.01% | 1194 |
|
|
2025
Q4 | $19.3M | Buy |
188,888
+169,674
| +883% | +$15.2M | 0.01% | 1128 |
|
|
2025
Q3 | $1.2M | Sell |
19,214
-64,281
| -77% | -$3.5M | ﹤0.01% | 3051 |
|
|
2025
Q2 | $4.35M | Sell |
83,495
-12,190
| -13% | -$544K | ﹤0.01% | 2005 |
|
|
2025
Q1 | $4.08M | Sell |
95,685
-7,518
| -7% | -$324K | ﹤0.01% | 2088 |
|
|
2024
Q4 | $3.15M | Sell |
103,203
-11,438
| -10% | -$322K | ﹤0.01% | 2423 |
|
|
2024
Q3 | $2.63M | Buy |
114,641
+83,365
| +267% | +$2.36M | ﹤0.01% | 2425 |
|
|
2024
Q2 | $903K | Sell |
31,276
-7,367
| -19% | -$172K | ﹤0.01% | 2982 |
|
|
2024
Q1 | $797K | Buy |
38,643
+5,729
| +17% | +$123K | ﹤0.01% | 3210 |
|
|
2023
Q4 | $890K | Buy |
32,914
+16,309
| +98% | +$428K | ﹤0.01% | 2922 |
|
|
2023
Q3 | $492K | Sell |
16,605
-40,701
| -71% | -$1.43M | ﹤0.01% | 3078 |
|
|
2023
Q2 | $2.05M | Sell |
57,306
-44,711
| -44% | -$1.28M | ﹤0.01% | 2192 |
|
|
2023
Q1 | $2.39M | Buy |
102,017
+84,481
| +482% | +$2.41M | ﹤0.01% | 1901 |
|
|
2022
Q4 | $477K | Sell |
17,536
-10,111
| -37% | -$463K | ﹤0.01% | 3214 |
|
|
2022
Q3 | $1.49M | Sell |
27,647
-3,386
| -11% | -$174K | ﹤0.01% | 2391 |
|
|
2022
Q2 | $1.25M | Sell |
31,033
-3,703
| -11% | -$183K | ﹤0.01% | 2445 |
|
|
2022
Q1 | $2.3M | Sell |
34,736
-39,913
| -53% | -$2.73M | ﹤0.01% | 2255 |
|
|
2021
Q4 | $7.47M | Buy |
74,649
+38,543
| +107% | +$3.99M | ﹤0.01% | 1579 |
|
|
2021
Q3 | $4.51M | Sell |
36,106
-45,589
| -56% | -$5.42M | ﹤0.01% | 1896 |
|
|
2021
Q2 | $10.1M | Buy |
81,695
+11,250
| +16% | +$1.51M | 0.01% | 1406 |
|
|
2021
Q1 | $10.8M | Buy |
70,445
+599
| +0.9% | +$90.5K | 0.01% | 1328 |
|
|
2020
Q4 | $9M | Buy |
69,846
+564
| +0.8% | +$64.9K | 0.01% | 1651 |
|
|
2020
Q3 | $7.74M | Sell |
69,282
-6,943
| -9% | -$635K | 0.01% | 1568 |
|
|
2020
Q2 | $6.18M | Buy |
76,225
+4,233
| +6% | +$341K | ﹤0.01% | 1676 |
|
|
2020
Q1 | $5.01M | Buy |
71,992
+54,345
| +308% | +$4.17M | ﹤0.01% | 1680 |
|
|
2019
Q4 | $1.38M | Buy |
17,647
+11,252
| +176% | +$811K | ﹤0.01% | 3402 |
|
|
2019
Q3 | $408K | Buy |
6,395
+4,110
| +180% | +$362K | ﹤0.01% | 4533 |
|
|
2019
Q2 | $197K | Buy |
2,285
+548
| +32% | +$41.9K | ﹤0.01% | 5286 |
|
|
2019
Q1 | $133K | Sell |
1,737
-759
| -30% | -$42.1K | ﹤0.01% | 5475 |
|
|
2018
Q4 | $94K | Buy |
+2,496
| New | +$92K | ﹤0.01% | 5703 |
|
Other funds holding GH
VPM
VCM
Citigroup's GH Position: Q1 2026 in Review
Citigroup reduced its Guardant Health (GH) stake by 7.8% in Q1 2026, selling an estimated $1.49M and leaving 174,072 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1194.
Citigroup first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $19.3M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.
- Citigroup held 174,072 shares of Guardant Health worth $16.1M as of Q1 2026.
- Citigroup sold 14,816 Guardant Health shares in Q1 2026, an estimated $1.49M.
- Guardant Health made up 0.01% of Citigroup's portfolio in Q1 2026, its #1194 holding.
- Citigroup first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
- Citigroup's Guardant Health position peaked at $19.3M in Q4 2025.
- 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.